Due to health concerns (see my post asking for your prayers https://greatawakening.win/p/1ASG09kssi/a-prayer-request-please/ ) ...my treatments have not started yet, but yesterday I started taking Ivermectin and Fenbendazole to get ahead of things. Is the Ivmt / Fenben that one can buy at Tractor Supply or other veterinarian store the very same as pharmacies would distribute? ...OR, is there a significant compounding difference between farm store-bought anti-parasites products and what we would get from a pharmacy?
You're viewing a single comment thread. View all comments, or full comment thread.
Comments (96)
sorted by:
Nay, nay, young Jedi knight.
If you check into the long term side effects of GLP1 drugs they include a diminished amount of muscle around the body and cardiac problems.
Please do due diligence before injesting/injecting GLP1 into ones body. The side effects can make you thin, or it can screw with parts of your body you'd not expect.
Please read my post and tell me where I referenced taking a peptide long term or even at recommended doses. The point was to add microdoses to fix insulin sensitivity.
Sometimes with a long term or on high dose people experience:
Lower calorie intake
Reduced appetite
Insufficient nutrition or resistance training
Those factors — not a direct toxic effect of GLP-1s on muscle tissue — are what most clinicians focus on.
There are strong cardiovascular outcome data showing that GLP-1 receptor agonists reduce heart disease events, even independent of weight loss:
The SELECT Trial and related analyses have shown reduced major cardiovascular events (e.g., heart attack, stroke) with semaglutide in people with overweight/obesity and heart disease risk, not just from weight loss alone. � Patient Daily +1
Some researchers suggest that GLP-1 therapies may also reduce inflammation, improve lipid profiles, and benefit endothelial health — all supportive of cardiovascular protection. � Patient Daily
There are rare reports of side effects like increased heart rate or electrolyte imbalances, but major long-term cardiac damage has not been shown in the clinical outcomes data.
You are correct that you did not state you were specifically talking about GLP1 drugs. I admit that freely. Buuuttttt, if someone, like me, cursory read the first sentence of your post, they might have not read your entire paragraph, could come away with the idea you were referring to GLP1. Sorry for not doing my due diligence.
Understood, and thanks for explaining. We are currently on the 3rd major form of this type of medicine and they are just going to keep getting better.
RFK jr, just announced that 19 peptides which were previously banned in the US are now legal to compound in pharmacies.